ARCHIVES

Alimta Granted Approval As NSCLC Continuation Therapy

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

November 14, 1975

ACS Finds 1 In 4 US Deaths From Cancer; Weiss Named NCI Centers Branch Chief.

January 18, 2002

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992

Nature Editorial Criticizes NCI PR Spending

March 15, 2013

NCI Information Officer Plays Key Role In Cancer Program

February 8, 1980

DRCCA Completes New Cancer control Research Guidelines

August 5, 1983